Total Funding
45
23
Total FundingVenture - Series Unknown raised
Growth Score 45 in past quarter
-1 pts
Heat Score 23 in past quarter
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
415107
Flex Biomedical develops treatments for orthopedic diseases and offers Flex Polymer, a synthetic polymer designed to treat osteoarthritis.
- Hideki Suzuki: Chief Scientific Officer
About the Company
Flex Biomedical, a Madison-based company founded in 2007, is developing innovative treatments for orthopedic diseases. The company's lead product, the Flex Polymerâ„¢, is a synthetic polymer designed to treat osteoarthritis, an incurable, debilitating joint disease that affects 27 million people in the United States and 100 million people
worldwide.

